Waldemar A. Schmidt
Oregon Health & Science University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Waldemar A. Schmidt.
Laryngoscope | 1998
Maureen M. Mulcahy; James I. Cohen; Peter E. Anderson; John Ditamasso; Waldemar A. Schmidt
The need for and extent of thyroid surgery for a thyroid nodule is usually primarily based on fine‐needle aspiration (FNA) and frozen section diagnosis. The relative role of these modalities in 66 patients who had undergone FNA and subsequent thyroidectomy with frozen section was investigated. Cases that demonstrated discordance between FNA and frozen section (n = 22; 33%) were identified, and all slides were re‐reviewed by a cytopathologist using current established cytologic criteria. A change in diagnosis was made in 13 cases with an increase in accuracy of FNA from 71% to 88%. The accuracy of frozen section (92%) did not change appreciably with re‐review (94%). The accuracy of FNA and frozen section combined was found to be 98%. The rate of discordance decreased from 33% to 13% with re‐review. When strict histologic and cytologic criteria are applied, FNA and frozen section are accurate and complementary methods that help in determining the operative management of thyroid masses. However, when FNA yields a diagnosis of “follicular neoplasm,” frozen section is unlikely to change this diagnosis.
American Journal of Surgery | 2002
Katherine T. Morris; John T. Vetto; John K. Petty; Sharon Lum; Waldemar A. Schmidt; SuEllen Toth-Fejel; Rodney F. Pommier
BACKGROUND The purpose of this study was to develop a rapid and accurate diagnostic test for palpable breast masses in women under age 40. METHODS Masses were evaluated utilitzing a modified triple test score (MTTS), which assigned scores of 1 point for benign, 2 points for suspicious, or 3 points for malignant findings from physical examination, ultrasonography, and fine needle aspiration. The MTTS was the sum of the three scores and was correlated with biopsy or follow-up. RESULTS Among 113 masses, 100 scored 3 points, 8 scored 4 points; all were benign. Three scored 5 points; 1 was malignant. Two scored >or=6 points: both were malignant. CONCLUSIONS The MTTS has 100% diagnostic accuracy when other than 5 points. Masses scoring <or=4 points are benign. Masses scoring >or=6 points may proceed to definitive therapy. Masses scoring 5 points (3%) require biopsy. This approach avoids open biopsy in the majority of cases, while capturing all malignancies.
Acta Cytologica | 1998
Patrick W. Heintz; Waldemar A. Schmidt; Rodney F. Pommier; John T. Vetto; John DiTomasso
BACKGROUND Carcinoma ex pleomorphic adenoma is a rare neoplasm of the salivary gland. This lesion, also known as malignant mixed tumor, occurs when a malignant tumor arises in the epithelial component of a pleomorphic adenoma. Reports of fine needle aspiration biopsy (FNAB) diagnosis of malignant mixed tumors are rare and have been limited to cases arising in the parotid. Cytologic features and diagnostic pitfalls of this uncommon neoplasm are presented. CASE A 75-year-old male presented with a nontender submandibular mass. The lesion had been present 12 months, with a recent increase in size. FNAB was performed, and the smears revealed a mixture of benign and malignant areas. The benign portion of the smears showed findings typical of pleomorphic adenoma. The malignant area showed large cells occurring singly and in groups. The malignant cells contained pleomorphic nuclei with irregular nuclear membranes and prominent macronucleoli; cytologically, they resembled cells from a poorly differentiated adenocarcinoma. CONCLUSION We present the first case of carcinoma ex pleomorphic adenoma of the submandibular gland correctly diagnosed by FNAB. This rare salivary gland malignancy can be accurately diagnosed on FNAB if strict criteria are applied.
Medical Care | 2003
Arden M. Morris; Christopher Flowers; Katherine T. Morris; Waldemar A. Schmidt; Rodney F. Pommier; John T. Vetto
Background. Physical examination, mammography, ultrasonography, and fine needle aspiration are traditionally used to guide further management of palpable breast masses, often leading to open biopsy of benign masses. The triple test score (TTS) integrates physical examination, mammography, and fine needle aspiration in the initial evaluation, limiting open biopsy. Objective. To compare cost‐effectiveness of TTS and traditional methods. Methods. The primary measure of clinical effectiveness, frequency of missed malignancy, was determined for each strategy using probabilities and outcomes from a systematic literature review. Costs were calculated using the Medicare resource‐based relative‐value scale. A decision‐analytic model compared costs of initial work‐up, costs per mass evaluated, and costs per malignancy diagnosed. Sensitivity analyses assessed the influence of variations in model assumptions. Results. In the base case, neither strategy led to undiagnosed breast cancer. However, open biopsy was required in 13% of benign masses using TTS versus 88% using the traditional strategy. The cost of the initial work‐up using traditional management was less than TTS (
Archives of Pathology & Laboratory Medicine | 2002
Steven L. Shapiro; Sean O. McMenomey; Priscilla W. Alexander; Waldemar A. Schmidt
377 vs.
Acta Cytologica | 1996
Mitchell Wachtel; Kenneth E. James; Margaret A. Miller; Kenneth B. Moody; Waldemar A. Schmidt
627), but cost per mass evaluated and cost per malignancy diagnosed (
American Journal of Surgery | 1995
John T. Vetto; Rodney F. Pommier; Waldemar A. Schmidt; Mitchell Wachtel; Polly M. Dubois; Maria K. Jones; Amy S. Thurmond
1793 vs.
Archives of Surgery | 2001
Katherine T. Morris; Rodney F. Pommier; Arden M. Morris; Waldemar A. Schmidt; Gregory Beagle; Priscilla W. Alexander; SuEllen Toth-Fejel; Josh Schmidt; John T. Vetto
925 and
Archives of Surgery | 1996
John T. Vetto; Rodney F. Pommier; Waldemar A. Schmidt; Heidi Eppich; Priscilla W. Alexander
5670 vs.
Archives of Surgery | 1998
Arden M. Morris; Rodney F. Pommier; Waldemar A. Schmidt; Richard Shih; Priscilla W. Alexander; John T. Vetto
2925) favored TTS, due to substantially reduced open biopsy. In sensitivity analyses, TTS cost varied most with changes in cost of initial evaluation, whereas the traditional strategy cost varied most with changes in open biopsy cost. Conclusions. The TTS provides equivalent diagnostic effectiveness but substantially lower cost than traditional management. Cost savings are based on decreased open biopsy, a major contributor to the cost of traditional evaluation in this model.